[HTML][HTML] Genetic counseling for prion disease: updates and best practices

JS Goldman, SM Vallabh - Genetics in Medicine, 2022 - Elsevier
Prion disease is a rare, fatal, and often rapidly progressive neurodegenerative disease. Ten
to fifteen percent of cases are caused by autosomal dominant gain-of-function variants in the …

Human prion disorders: review of the current literature and a twenty-year experience of the National Surveillance Center in the Czech Republic

N Jankovska, R Rusina, M Bruzova, E Parobkova… - Diagnostics, 2021 - mdpi.com
Human prion disorders (transmissible spongiform encephalopathies, TSEs) are unique,
progressive, and fatal neurodegenerative diseases caused by aggregation of misfolded …

Challenges and advances in antemortem diagnosis of human transmissible spongiform encephalopathies

LM Ascari, SC Rocha, PB Gonçalves… - … in bioengineering and …, 2020 - frontiersin.org
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, arise
from the structural conversion of the monomeric, cellular prion protein (PrPC) into its …

Genetic movement disorders commonly seen in Asians

P Jagota, SY Lim, PK Pal, JY Lee… - Movement Disorders …, 2023 - Wiley Online Library
The increasing availability of molecular genetic testing has changed the landscape of both
genetic research and clinical practice. Not only is the pace of discovery of novel disease …

Detection of prions in brain homogenates and CSF samples using a second-generation RT-QuIC assay: A useful tool for retrospective analysis of archived samples

T Moško, S Galušková, R Matěj, M Brůžová, K Holada - Pathogens, 2021 - mdpi.com
The possibilities for diagnosing prion diseases have shifted significantly over the last 10
years. The RT-QuIC assay option has been added for neuropsychiatric symptoms …

THαβ immunological pathway as protective immune response against prion diseases: an insight for prion infection therapy

A Tsou, PJ Chen, KW Tsai, WC Hu, KC Lu - Viruses, 2022 - mdpi.com
Prion diseases, including Creutzfeldt–Jakob disease, are mediated by transmissible
proteinaceous pathogens. Pathological changes indicative of neuro-degeneration have …

Human prion diseases and the prion protein–what is the current state of knowledge?

R Nafe, CT Arendt, E Hattingen - Translational Neuroscience, 2023 - degruyter.com
Prion diseases and the prion protein are only partially understood so far in many aspects.
This explains the continued research on this topic, calling for an overview on the current …

[HTML][HTML] Genetic and pathological features encipher the phenotypic heterogeneity of Gerstmann-Sträussler-Scheinker disease

Z Chen, Y Kong, J Zhang, WQ Zou, L Wu - Neurobiology of Disease, 2024 - Elsevier
Objectives To elucidate and compare the genetic, clinical, ancillary diagnostic, and
pathological characteristics across different Gerstmann-Sträussler-Scheinker disease (GSS) …

Dopaminergic neurodegeneration in Gerstmann–Sträussler–Scheinker (P102L) disease: insights from imaging and pathological examination

KI Irie, H Honda, T Tateishi, S Mori… - Frontiers in …, 2024 - frontiersin.org
Gerstmann–Sträussler–Scheinker (GSS) disease is an inherited prion disease characterized
by dementia, cerebellar ataxia, and painful sensory disturbances. GSS is pathologically …

The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?

H Kishida, N Ueda, F Tanaka - Expert Review of …, 2023 - Taylor & Francis
Introduction Before the introduction of MRI diffusion-weighted images (DWI), the diagnosis of
Creutzfeldt–Jakob disease (CJD) relied upon nonspecific findings including clinical …